iData is excited to announce one of our brand-new 2022 market reports on the U.S. orthopedic biomaterials market. As expected, 2020 was an unusual year mainly due to the global COVID-19 pandemic, which caused a 6.7% decrease in the U.S. Orthopedic Biomaterials Market from 2019 to 2020. Despite a large majority of orthopedic surgeries
iData’s analysts work extensively to retrieve data and source both syndicated and custom market research reports. Due to their in-depth understanding of the markets and their first-hand experience with the data, we have asked some insightful questions on the European market for orthopedic biomaterials to assist you in making better strategic decisions. WHAT ARE ORTHOPEDIC
Did you know there are over 8.9 million orthopedic procedures performed in the United States each year, with the orthopedic biomaterials market showing the greatest forecast growth? As this market continues to grow and innovative technologies are being designed, we have compiled a list of the top companies within different categories of the orthopedics market including: Orthopedic
The growing elderly demographic has been a considerable market driver within the orthopedic biomaterials market, the incidence of osteoarthritis and other forms of degenerative diseases have also been on the rise. In an effort to find a cure for such diseases researchers have been investigating the abilities of smart biomaterials. Smart biomaterials autonomously respond to
Researchers at Duke University have developed an adenosine-sequestering bone bandage able to naturally trap adenosine at the site of a break, accelerating recovery and improving bone repair. The research team observed an increase in adenosine levels in patients with bone injuries, however, the amount available to the break site may be limited depending on the
Register to receive a free Small Bone and Joint Devices Market Analysis, Size, and Trends Report synopsis and brochure. During a press release, there was a massive development in the small bone and joints market, where Wright Medical sold all issued and outstanding ordinary shares of the company to the Stryker Corporation. The agreement between
Register to receive a free Orthobiologics Market Analysis, Size, and Trends Report synopsis and brochure. When someone injures their knee and their cartilage becomes damaged, surgery is usually required to repair the tissue. Currently, microfracture is the most common type of operation to treat damaged cartilage. New Jersey-based Regentis Biomaterials, a global biomaterials company, is
Register to receive a free U.S. Market Report Suite for Orthopedic Biomaterials report synopsis and brochure Bone infections are notoriously tricky to treat, and antibiotics are frequently prescribed. Now, researchers at Georgia Tech have created a hydrogel material that can be used to treat bone infections and even prevent them from happening following surgery. The injectable hydrogel
Register to receive a free synopsis and brochure. Browse the Report Library. Arthrex is a global medical company focused in orthopedic product development and education, and was founded in 1981. Today it is a privately held organization headquartered in Southwest Florida. Arthrex has an additional global division in Germany and several subsidiaries and distribution centers in Europe,
Register to receive a free U.S. Market Report Suite for Orthopedic Biomaterials report synopsis and brochure Medtronic announced the launch of the Grafton™ Demineralized Bone Matrix (DBM) for spine and orthopedic procedures on February 28th, 2019. Grafton™ DBM is the first ever demineralized bone matrix product available in Japan, which is the world’s second largest
